Trimi Health review
A low-cost, GLP-1-focused telehealth with an unusually deep library of dosing and cost guidance.
Our verdict
Trimi Health pairs one of the lower entry prices we track with genuinely thorough dosing and cost guides and 50-state coverage. It also lists the investigational triple-agonist retatrutide — interesting, but not an approved therapy, so treat that option with extra caution.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- GLP-1 telehealth
- Access
- Compounded GLP-1 from ~$99/mo, all 50 states
- Medications
- Semaglutide · Tirzepatide · Branded · Retatrutide
- Visit
- Async intake
- Updated
- July 2026
What it is
Trimi Health is a GLP-1-focused weight-loss telehealth offering compounded semaglutide and tirzepatide, some branded options, and — unusually — the investigational triple agonist retatrutide, backed by a deep library of dosage, cost, and comparison guides. It covers all 50 states.
How it works
Online prescribing with an emphasis on educating patients through its guide library. The depth of dosing and cost content is a real plus for people who want to understand what they're doing.
Pricing transparency
Trimi advertises compounded GLP-1 from around $99/mo — among the lower entry points in this roundup — with 50-state coverage. Confirm how pricing steps up at higher doses and on refills.
Branded vs compounded
Compounded semaglutide and tirzepatide, plus some branded options and the investigational retatrutide. Retatrutide is not FDA-approved and remains in clinical development — a maturity and safety caveat that a low price shouldn't obscure.
Pros and watch-outs
What we like
- Low entry price (~$99/mo)
- Compounded and some branded options
- Unusually deep dosing and cost guidance
- All 50 states
Watch-outs
- Lists investigational retatrutide, which is not an approved therapy
- Standard compounded-GLP-1 safety caveats apply
Best for
Cost-conscious patients who want low pricing plus thorough dosing guidance.
Who should look elsewhere
Anyone who wants only FDA-approved, branded medication and no investigational options in the mix.
How Trimi Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Found
Putting insurance benefits toward GLP-1 treatment
See Found → - yourEra
A low-cost entry point into compounded GLP-1 treatment
See yourEra → - Breeze Meds
Compounded GLP-1 with named-pharmacy transparency
See Breeze Meds →
Access & cost · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of Trimi Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is Trimi Health cheap?
- Trimi advertises compounded GLP-1 from around $99/mo, which is among the lower entry points we track. As with any provider, confirm how the price changes as your dose increases and on refills.
- Does Trimi Health offer retatrutide?
- Trimi lists the investigational triple-agonist retatrutide alongside semaglutide and tirzepatide. Retatrutide is not FDA-approved and is still in clinical trials, so it carries more uncertainty than the established GLP-1s.